Breast Cancer Research and Treatment Oncology

HER2 status change in residual breast carcinoma after neoadjuvant HER2-targeted therapy in patients with HER2-positive breast cancer

Payu Raval, Qingqing Ding, Puneet Singh, Alaaeddin Alrohaibani, Hongxia Sun, Di Ai, Kerollos Nashat Wanis, Ming Zhao, Hui Chen, Vicente Valero, Mariana Chavez-MacGregor, Aysegul Sahin
Springer Nature · 2026-09-28 · DOI 10.1007/s10549-026-08088-z

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →